GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Inno-Gene SA (WAR:IGN) » Definitions » Shiller PE Ratio

Inno-Gene (WAR:IGN) Shiller PE Ratio : 270.00 (As of Sep. 24, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Inno-Gene Shiller PE Ratio?

As of today (2024-09-24), Inno-Gene's current share price is zł2.70. Inno-Gene's E10 for the quarter that ended in Jun. 2024 was zł0.01. Inno-Gene's Shiller PE Ratio for today is 270.00.

The historical rank and industry rank for Inno-Gene's Shiller PE Ratio or its related term are showing as below:

WAR:IGN' s Shiller PE Ratio Range Over the Past 10 Years
Min: 23.44   Med: 63.95   Max: 430
Current: 307.03

During the past years, Inno-Gene's highest Shiller PE Ratio was 430.00. The lowest was 23.44. And the median was 63.95.

WAR:IGN's Shiller PE Ratio is ranked worse than
97.4% of 77 companies
in the Medical Diagnostics & Research industry
Industry Median: 28.24 vs WAR:IGN: 307.03

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Inno-Gene's adjusted earnings per share data for the three months ended in Jun. 2024 was zł-0.068. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is zł0.01 for the trailing ten years ended in Jun. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Inno-Gene Shiller PE Ratio Historical Data

The historical data trend for Inno-Gene's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inno-Gene Shiller PE Ratio Chart

Inno-Gene Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 216.51 58.86 145.86

Inno-Gene Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 53.90 40.57 145.86 86.45 202.41

Competitive Comparison of Inno-Gene's Shiller PE Ratio

For the Diagnostics & Research subindustry, Inno-Gene's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inno-Gene's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Inno-Gene's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Inno-Gene's Shiller PE Ratio falls into.



Inno-Gene Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Inno-Gene's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=2.70/0.01
=270.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inno-Gene's E10 for the quarter that ended in Jun. 2024 is calculated as:

For example, Inno-Gene's adjusted earnings per share data for the three months ended in Jun. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=-0.068/150.9971*150.9971
=-0.068

Current CPI (Jun. 2024) = 150.9971.

Inno-Gene Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201409 0.076 100.611 0.114
201412 0.293 100.122 0.442
201503 -0.002 100.041 -0.003
201506 -0.026 100.448 -0.039
201509 0.007 99.634 0.011
201512 -0.139 99.471 -0.211
201603 -0.135 98.983 -0.206
201606 -0.201 99.552 -0.305
201609 0.021 99.064 0.032
201612 -0.163 100.366 -0.245
201703 -0.076 101.018 -0.114
201706 0.071 101.180 0.106
201709 0.131 101.343 0.195
201712 0.015 102.564 0.022
201803 -0.025 102.564 -0.037
201806 0.004 103.378 0.006
201809 0.146 103.378 0.213
201812 -0.051 103.785 -0.074
201903 0.016 104.274 0.023
201906 0.005 105.983 0.007
201909 -0.072 105.983 -0.103
201912 0.023 107.123 0.032
202003 -0.007 109.076 -0.010
202006 0.120 109.402 0.166
202009 0.039 109.320 0.054
202012 -0.087 109.565 -0.120
202103 -0.048 112.658 -0.064
202106 0.894 113.960 1.185
202109 0.205 115.588 0.268
202112 -0.139 119.088 -0.176
202203 0.619 125.031 0.748
202206 -0.209 131.705 -0.240
202209 -0.272 135.531 -0.303
202212 -0.061 139.113 -0.066
202303 -0.055 145.950 -0.057
202306 -0.079 147.009 -0.081
202309 -0.098 146.113 -0.101
202312 -0.858 147.741 -0.877
202403 -0.035 149.044 -0.035
202406 -0.068 150.997 -0.068

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Inno-Gene  (WAR:IGN) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Inno-Gene Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Inno-Gene's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Inno-Gene Business Description

Traded in Other Exchanges
N/A
Address
Poznan Science Park - Technology, 46 Border Section, Poznan, POL, 61-612
Inno-Gene SA operates a DNA research facility that deals with genetic diagnostics, research and development. The company provides services in the field of genetic medical diagnosis, including diagnosis of microbial infections and innate predispositions.

Inno-Gene Headlines